Clinical Trials Logo

Cardiac Surgical Procedures clinical trials

View clinical trials related to Cardiac Surgical Procedures.

Filter by:

NCT ID: NCT00336908 Completed - Inflammation Clinical Trials

Inflammatory Responses to Lipid Emulsions in Children Before and After Open Heart Surgery

Start date: November 2005
Phase: Phase 2/Phase 3
Study type: Interventional

This study is a blinded, randomized, controlled prospective trial comparing immune response (sepsis, inflammatory response, pulmonary vasoconstriction) in 2 groups of infants less than 3-month old receiving pre and post cardiopulmonary bypass surgery. The infants will receive 1 out of the 2 following intravenous lipid preparations: Soybean Oil (n-6), or a combination of Medium Chain Triglyceride i.e. coconut oil, Long Chain Triglyceride i.e. Soybean Oil, and Fish Oil (MCT:LCT:FO). There will be 16 subjects in each group.

NCT ID: NCT00282698 Completed - Hyperglycemia Clinical Trials

Outcomes With Tight Control of Hyperglycemia in Cardiac Surgery Patients

Start date: July 2004
Phase: Phase 3
Study type: Interventional

Patients with or without diabetes may have high blood sugar levels due to stress response of the body during heart surgery. This study is being done to determine if maintaining normal blood sugar levels during open-heart surgery by using intravenous insulin results in a lesser incidence of death, wound infections in the chest, disturbances of heart rhythm, kidney failure, stroke and prolonged time on the breathing machine (artificial ventilation) within 30 days after surgery.

NCT ID: NCT00122018 Completed - Clinical trials for Kidney Failure, Chronic

An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery

Start date: May 2002
Phase: Phase 2
Study type: Interventional

Patients with abnormal kidney function are at increased risk for complications following heart surgery, including worsening kidney function possibly requiring dialysis, a prolonged stay in the critical care unit and hospital, and the increased risk of death. Prior attempts at kidney protection for heart surgery patients have had mixed results. Two medicines, fenoldopam and N-acetylcysteine, have been shown to protect kidney function in other circumstances that cause kidney stress. The purpose of this study is to determine whether these medications will help to maintain the function of diseased kidneys during heart surgery.